Expectations for Phase-Appropriate Drug Substance and Drug Product Specifications for Early-Stage Protein Therapeutics

Published 2018 View Full Article

Authors

Keywords

antibody drug(s), monoclonal antibody(s), antibody drug conjugate(s) (ADC), physicochemical properties, drug-like property(s), protein aggregation, analytical chemistry, degradation product(s)

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2018-12-07

DOI

10.1016/j.xphs.2018.11.042

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now